These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A case of parenteral zolpidem dependence with opioid-like withdrawal symptoms. Kao CL; Huang SC; Yang YJ; Tsai SJ J Clin Psychiatry; 2004 Sep; 65(9):1287. PubMed ID: 15367062 [No Abstract] [Full Text] [Related]
6. Intravenous zolpidem injection in a zolpidem abuser. Hsu WY; Chiu NY Pharmacopsychiatry; 2013 May; 46(3):121-2. PubMed ID: 23093474 [TBL] [Abstract][Full Text] [Related]
7. Epidemiological evidence for a low abuse potential of zolpidem. Soyka M; Bottlender R; Möller HJ Pharmacopsychiatry; 2000 Jul; 33(4):138-41. PubMed ID: 10958262 [TBL] [Abstract][Full Text] [Related]
8. Zolpidem-associated hallucinations and serotonin reuptake inhibition: a possible interaction. Elko CJ; Burgess JL; Robertson WO J Toxicol Clin Toxicol; 1998; 36(3):195-203. PubMed ID: 9656974 [TBL] [Abstract][Full Text] [Related]
9. Hallucinations with zolpidem and fluoxetine in an impaired driver. Coleman DE; Ota K J Forensic Sci; 2004 Mar; 49(2):392-3. PubMed ID: 15027567 [TBL] [Abstract][Full Text] [Related]
10. Possible paroxetine-zolpidem interaction. Katz SE Am J Psychiatry; 1995 Nov; 152(11):1689. PubMed ID: 7485639 [No Abstract] [Full Text] [Related]
11. Dependence on zolpidem in high dose. Vartzopoulos D; Bozikas V; Phocas C; Karavatos A; Kaprinis G Int Clin Psychopharmacol; 2000 May; 15(3):181-2. PubMed ID: 10870877 [TBL] [Abstract][Full Text] [Related]
12. Soyka M, Bottlender R, Möller H-J; Epidemiological evidence for a low abuse potential of zolpidem; Pharmacopsychiatry 2000, 33: 138 - 141. Engfer A Pharmacopsychiatry; 2002 Mar; 35(2):81; author reply 81-2. PubMed ID: 11951152 [No Abstract] [Full Text] [Related]